XM does not provide services to residents of the United States of America.
C
C

Cadence

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Atlassian, Crowdstrike Holdings, CS Disco

U.S. RESEARCH ROUNDUP-Atlassian, Crowdstrike Holdings, CS Disco July 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Atlassian, Crowdstrike Holdings and CS Disco, on Tuesday. HIGHLIGHTS * Atlassian Corp TEAM.O : Piper Sandler raises to overweight from neutral * Crowdstrike Holdings Inc CRWD.O : Piper Sandler cuts to neutral from overweight * CS Disco Inc LAW.N : JP Morgan cuts to underweight from neutral * Principa
C
C
C
N
P
W
A
C
A
F
L
P
U

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Autodesk Inc ADSK.OQ +5.0% Trade Desk Inc TTD.OQ +4.7% Intuit Inc INTU.OQ +4.1% Tesla Inc TSLA.OQ +4.1% Cadence Design Systems Inc CDNS.OQ +3.4% Bottom Performers Percent Change Exelon Corp EXC.OQ -3.8% Illumina Inc ILMN.OQ -3.3% T-Mobile US Inc TMUS.OQ -3.1% Warner Bros Discovery Inc WBD.OQ -3.0% Lululemon Athletica Inc LULU.OQ -3.0% The Nasdaq 100 .NDX gained 215.29 points, or 1
A
C
D
E
I
I
L
T
T
U
T

Cadence Design Systems Files For Offering Of Up To 1.74 Mln Shares By Selling Stockholders

BRIEF-Cadence Design Systems Files For Offering Of Up To 1.74 Mln Shares By Selling Stockholders June 6 (Reuters) - Cadence Design Systems Inc CDNS.O : CADENCE DESIGN SYSTEMS INC FILES FOR OFFERING OF UP TO 1.74 MILLION SHARES BY THE SELLING STOCKHOLDERS - SEC FILING Source text for Eikon: [ID:n0000813672-24-000138] Further company coverage: CDNS.O
C

Cadence Design Systems Files For Shelf Of Up To 1.7 Mln Shares Of Common Stock By Selling Stockholders

BRIEF-Cadence Design Systems Files For Shelf Of Up To 1.7 Mln Shares Of Common Stock By Selling Stockholders June 5 (Reuters) - Cadence Design Systems Inc CDNS.O : CADENCE DESIGN SYSTEMS INC FILES FOR SHELF OF UP TO 1.7 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Source text for Eikon: [ID:n0000813672-24-000131] Further comp
C

U.S. Elevance Health, Wesco International, WW Grainger

U.S. RESEARCH ROUNDUP-Elevance Health, Wesco International, WW Grainger May 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies including Elevance Health, Wesco International and WW Grainger, on Thursday. HIGHLIGHTS * Cigna Group CI.N : JP Morgan raises target price to $435 from $432 * Elevance Health Inc ELV.N : JP Morgan raises target price to $631 from $628 * Uipath Inc PATH.N : TD Cowen cuts to hold from buy * Wesco Internati
A
C
C
E
F
S
A
E
H
W
A
L
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.